Michael Zinda insider trades
Open-market stock purchases and sales by Michael Zinda, EVP, CHIEF SCIENTIFIC OFFICER at Repare Therapeutics Inc, from SEC Form 4 filings since Jun 18, 2020.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- RPTX Repare Therapeutics Inc: 32 sales, last Mar 12, 2025